- Reframe Daily
- Archive
- Page 3
Past Issues
Reframe Daily: Fish oil helps burn patients heal faster, new probiotic spray eases BV, and mice beat type 1 diabetes
A small trial found fish oil calmed inflammation and steadied blood sugar in people with serious burns; a clinic program for first-episode psychosis sharply cut the risk of later schizophrenia; a vaginal probiotic spray improved symptoms of bacterial vaginosis; a combo of tumor “microwave” ablation plus dual immunotherapy showed promise for tough pancreatic cancer; and an antibody-based transplant approach completely reversed type 1 diabetes in mice without long-term chemo drugs.
Reframe Daily: New heart valve, kidney-saving combo pill, and a stool test that reads your gut
Today’s research drop: a catheter-placed heart valve that helps people too fragile for open-heart surgery, a new pill combo that cut kidney-damaging protein in urine, and a stool test that can read your gut’s immune cells one by one—plus two early-stage ways to protect hearts and aging guts in the future.
Reframe Daily: New nerve treatment for stubborn blood pressure, plus DNA clues for thyroid disease and sharper cancer surgery
Today’s health news brings a nerve treatment that lowered blood pressure in hard-to-treat patients, a DNA risk score that flags people likely to get thyroid disease, a lab test that spots hidden lung germs, a better way to see cancer edges in surgery, and a new brain “zinc switch” that could guide future nerve-protecting drugs.
Reframe Daily: Iron + fiber for kids with HIV, pig kidney progress, and a gut fungus that calms colitis
Today’s studies show a simple iron-and-fiber mix making treatment easier for children with HIV, a gene-edited pig kidney working in a human body for weeks, and a gut fungus plus new cell “switches” that could someday ease colitis, diabetes, and cancer.
Reframe Daily: Nose spray for faster healing and a nasal HPV cancer vaccine in the lab
Scientists tested a love-hormone nose spray, pre-surgery “training,” sound-wave brain openings, gene fixes for hearing loss, and a nasal HPV cancer vaccine—each pushing healing and cancer control forward in new ways.
Reframe Daily: Hot flashes eased without pills; tumor-zapping helps; new shield for implant infections
Self-guided hypnosis cooled hot flashes; ablation + immunotherapy held lung cancer longer; a lab “scaffold” shot blocked implant staph—plus spleen-targeting nanoparticles and a safer oral immune booster.
Reframe Daily: Dialysis plan speeds kidney recovery; early Hep B cure sign; mRNA shots last longer
An ICU study used fewer dialysis sessions and got more kidneys working again; a mid-stage trial found an RNA add-on helped more people clear signs of hepatitis B; new delivery and chemistry could make flu mRNA shots work better and last longer; and one simple test reads proteins and genes from the same sample.
Reframe Daily: Psoriasis pill rivals shots; allergy med relieves ER vertigo fast; some can skip breast-cancer radiation
Plus: a targeted kidney drug slowed IgA damage that can lead to dialysis, and a nose-spray H5N1 flu vaccine showed strong, broad immunity in an early human study.
Reframe Daily: Many after mastectomy can skip radiation; antibody cuts kidney relapses; psoriasis pill works
A 10-year trial shows many women who had a mastectomy can safely skip chest-wall radiation. An antibody drug kept tough kidney disease from coming back, an oral IL-23 blocker eased psoriasis, a one-shot Lassa vaccine looked safe in people, and a “teach-the-immune-system” shot for knee arthritis did what doctors hoped in early testing.
Reframe Daily: 2-month HIV shots match daily pills for 2 years; AR helps nerve-tumor surgery
Plus: a rare gene change in esophagus cancer responded to a newer cancer pill; a new RNA tool fixed gene messages and cut cholesterol in mice; and dialing down a liver-scar switch slowed fibrosis.
Reframe Daily: Diabetes drug cuts stroke risk; new COVID blocker and mosquito virus antibody show promise
A stroke-prevention win from an existing diabetes drug, a coronavirus enzyme blocker that stopped COVID in mice, and antibodies that neutralize chikungunya virus—all point to faster paths from lab to clinic.